Epsilon Healthcare Limited (FRA:9TH0)

Market Cap	4.76M +8.3%
Revenue (ttm)	5.34M +67.7%
Net Income	-726.32K
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.0050
Previous Close	0.0050
Day's Range	0.0050 - 0.0050
52-Week Range	0.0050 - 0.0145
Beta	n/a
RSI	35.93
Earnings Date	May 29, 2026

About Epsilon Healthcare

Epsilon Healthcare Limited, together with its subsidiaries, engages in the healthcare business in Australia. The company operates in two segments, Contract Development and Manufacturing Activities; and Telehealth Medical Practice Services. It is involved in the healthcare and clinics operation; pharmaceutical contract development and manufacturing; development and manufacturing of active pharmaceutical ingredients and finished formulations; and provision of pharmacy services and patient care. The company was formerly known as THC Global Group L...

• Industry: Pharmaceutical Preparations
• Founded: 2016
• Country: Australia
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 9TH0

Financial Performance

In 2025, Epsilon Healthcare's revenue was 9.39 million, an increase of 67.74% compared to the previous year's 5.60 million. Losses were -1.28 million, -76.73% less than in 2024.

Financial numbers in AUD